Source link : https://newshealth.biz/health-news/novel-lupus-drugs-continue-to-shine-in-extended-early-data/
LONDON — Two investigational drugs for lupus with encouraging primary phase II results yielded more good news from follow-on studies, reports here indicated. The Toll-like receptor (TLR) inhibitor enpatoran showed no diminution and perhaps some increase in efficacy for patients with cutaneous and systemic lupus with 48 weeks of additional treatment beyond the original 24 […]
The post Novel Lupus Drugs Continue to Shine in Extended Early Data first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-05 17:52:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8